Dallan Murray

Insider Reports History

Entity
Individual
Location
215 First Street, Cambridge, MA
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Dallan Murray
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dallan Murray:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Chief Customer Officer Common Stock 38.2K $3.83M $100.13 Mar 10, 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Performance Restricted Stock Units 17.5K $2.06M $117.51 Feb 11, 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Performance Stock Units 0 $0 $101.34 Mar 7, 2025 Direct
Sarepta Therapeutics, Inc. Chief Customer Officer Stock Options (right to buy) 16.6K Mar 10, 2025 Direct

Insider Reports Filed by Dallan Murray

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRPT Sarepta Therapeutics, Inc. Mar 7, 2025 6 -$374K 4 Mar 11, 2025 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Mar 6, 2025 4 -$950K 4 Mar 10, 2025 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2025 1 -$171K 4 Mar 6, 2025 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Mar 3, 2025 1 -$73.8K 4 Mar 4, 2025 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Feb 11, 2025 1 $0 4 Feb 13, 2025 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Jun 21, 2024 5 -$387K 4 Jun 25, 2024 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. May 2, 2024 1 -$509K 4 May 6, 2024 Chief Customer Officer
SRPT Sarepta Therapeutics, Inc. Apr 24, 2024 0 $0 3 May 6, 2024 Chief Customer Officer